{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-116632","form_type":"8-K","ticker":"ACXP","cik":"0001736243","company_name":"Acurx Pharmaceuticals, Inc.","filed_at":"2026-10-16T20:30:35+00:00","discovered_at":"2026-10-16T20:32:00.273943+00:00","generated_at":"2026-10-16T20:32:03.440220+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Acurx holders re-elect Luci, Dean as Class II directors; ratify CohnReznick for FY2026","bullets":["Annual meeting held Oct 16, 2026; record date Aug 20, 2026 with 5,471,297 shares outstanding; quorum of 2,890,899 shares, or 52.83%.","David P. Luci re-elected with 1,187,323 votes for and 73,804 withheld; Jack H. Dean with 1,203,310 for and 57,817 withheld.","Both Class II directors serve three-year terms expiring in 2029; broker non-votes totaled 1,629,772 on the director proposals.","Stockholders ratified CohnReznick LLP as independent registered public accounting firm for fiscal year ending Dec 31, 2026: 2,877,193 for, 8,473 against, 5,233 abstentions.","Two proposals were submitted, per the definitive proxy statement filed Sept 1, 2026; no other business reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-116632","json":"https://secwatch.observer/filing/0001104659-26-116632.json","markdown":"https://secwatch.observer/filing/0001104659-26-116632.md","text":"https://secwatch.observer/filing/0001104659-26-116632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926116632/0001104659-26-116632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736243/000110465926116632/tm2627481d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-16T20:32:03.440220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}